Close
ThinkAdvisor

Portfolio > Investment VIPs

Zurich Unit Turns Prescription Drug Royalties Into Collateral

X
Your article was successfully shared with the contacts you provided.

NU Online News Service, Aug. 10, 1:56 p.m. – The Centre Group, Hamilton, Bermuda, an arm of Zurich Financial Services Group, says it has used an unusual investment strategy to help Royalty Pharma A.G. Schaffhausen, Switzerland, a pharmaceutical company, get $60 million in loans.

Centre helped Royalty Pharma get the financing by turning the expected royalty streams from a portfolio of nine prescription drugs that are already on the market, and another drug that is still in development, into collateral.